Chapter 86
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
1448 PART 5 ■ Anesthetic, Surgical, and Interventional Procedures: Considerations<br />
TABLE <strong>86</strong>-8. Reference Values (Mean [Boundary]) for Coagulation Tests in Term and Premature (30–36 g.w.) Babies<br />
Coagulation test Day 1 Day 5 Day 30 Adult<br />
Premature infants<br />
PT (sec) 13.0 (10.6–16.2) 12.5 (10.0–15.3) 11.8 (10.0–13.6) 12.4 (10.8–13.9)<br />
APTT (sec) 53.6 (27.5–79.4) 50.5 (26.9–74.1) 44.7 (26.9–62.5) 33.5 (26.6–40.3)<br />
TCT (sec) 24.8 (19.2–30.4) 24.1 (18.8–29.4) 24.4 (18.8–29.9) 25.0 (19.7–30.3)<br />
Fibrinogen (g/L) 2.43 (1.50–3.73) 2.80 (1.60–4.18) 2.54 (1.50–4.14) 2.78 (1.56–4.00)<br />
Coagulation inhibitors<br />
AT III (U/mL) 0.38 (0.14–0.62) 0.56 (0.30–0.82) 0.59 (0.37–0.81) 1.05 (0.79–1.31)<br />
Protein C (U/mL) 0.28 (0.12–0.44) 0.31 (0.11–0.51) 0.37 (0.15–0.59) 0.96 (0.64–1.28)<br />
Term infants<br />
PT (sec) 13.0 (10.1–15.9) 12.4 (10.0–15.3) 11.8 (10.0–14.3) 12.4 (10.8–13.9)<br />
APTT (sec) 42.9 (31.3–54.5) 42.6 (25.4–59.8) 40.4 (32.0–55.2) 33.5 (26.6–40.3)<br />
TCT (sec) 23.5 (19.0–28.3) 23.1 (18.0–29.2) 24.3 (19.4–29.2) 25.0 (19.7–30.3)<br />
Fibrinogen (g/L) 2.83 (1.67–3.99) 3.12 (1.62–4.62) 2.70 (1.62–3.78) 2.78 (1.56–4.00)<br />
Coagulation inhibitors<br />
AT III (U/mL) 0.63 (0.39–0.87) 0.67 (0.41–0.93) 0.78 (0.48–1.08) 1.05 (0.79–1.31)<br />
Protein C (U/mL) 0.35 (0.17–0.53) 0.50 (0.22–0.78) 0.63 (0.33–0.93) 0.96 (0.64–1.28)<br />
PT prothrombin time; APTT activated partial thromboplastin time; TCT thrombin clotting time; AT III antithrombin III.<br />
Adapted from Andrew et al. 144<br />
When major surgery is planned a preoperative coagulation screen<br />
consisting of prothrombin time, activated partial thromboplastin<br />
time, and platelet count should be performed before surgery.<br />
The use of thromboelastography has recently been described<br />
also in neonates and infants. Using this technique, children with<br />
complex congenital heart disease have been found to have a<br />
functionally intact coagulation-fibrinolytic system working at a<br />
lower level than in healthy infants, indicating a reduction in the<br />
hemostatic potential with less reserve. 97 Using the same techno -<br />
logy, the effects of various colloid alternatives were analyzed in<br />
infants (3–15 kg). 98 In this investigation, the use of gelatins as an<br />
alternative to albumin was suggested since the use of hydroxyethyl<br />
starch affected the overall coagulation process the most.<br />
Diagnostic Investigations<br />
Special investigations can be required after taking the medical<br />
history and obtaining results from the laboratory testing. The most<br />
common preoperative investigations are chest radiography,<br />
echocardiography and ultrasonic head scans.<br />
Chest X-Rays<br />
Chest radiographs should be obtained in all patients with cardio -<br />
respiratory symptoms. Not only will this investigation provide the<br />
anesthesiologist with information regarding the severity of various<br />
conditions but it can also provide information if further treatment<br />
might optimize the patients condition before anesthesia and<br />
surgery. Thus, based on the chest radiograph, surgery might be<br />
postponed in order to re-expand atelectatic lung tissue or to<br />
reduce interstitial edema by intensifying diuretic treatment.<br />
Ultrasonographic Examinations<br />
Echocardiography should be performed liberally not only to search<br />
for associated congenital heart disease but also to more precisely<br />
estimate the intravascular volume status. Echocardiography is also<br />
useful in order to determine if the ductus arteriosus still remains<br />
open and to determine the possible presence of pulmonary<br />
hypertension and right-to-left shunting.<br />
Due to the existence of an open fontanel ultrasonic head scans<br />
provide the unique opportunity for investigating the intracranial<br />
contents of the neonate (for the vein of Galen for instance). In<br />
term neonates, this investigation rarely provides crucial infor -<br />
mation since intracranial hemorrhage is unusual in this group.<br />
However, premature infants have an increased risk for such<br />
hemorrhages with the highest risk seen in the most prematurely<br />
born babies. Before performing anesthesia in such premature<br />
infants, it might be wise to perform an ultrasonic head scan in<br />
order to document any pre-existing problem and, thus, escape the<br />
responsibility for any hemorrhages which have already occurred<br />
prior to the involvement of the anesthesiologist. 99<br />
PREANESTHETIC MANAGEMENT<br />
Premedication<br />
If the neonate is judged to be in pain preoperatively, low and<br />
titrated doses of morphine are appropriate. The response to<br />
morphine in this age group is variable and doses of 10 to 20 g/kg<br />
should be administered intravenously until adequate pain relief is<br />
achieved. In case of difficult venous access where an inhalational<br />
induction is planned, subcutaneous or intramuscular atropine<br />
(10–20 g/kg; minimum 100 g) is often useful to counteract<br />
parasympathetic reflexes before the placement of a reliable venous<br />
line. In case of intravenous induction, atropine can be given<br />
intravenously (10 g/kg; minimum 100 g) just before the start of<br />
the anesthetic. Apart from these specific situations, no preme -<br />
dication is usually required in the neonatal period.<br />
Parental Presence During Induction<br />
In older patients, parental presence can be helpful, although cer -<br />
tain practitioners still find this practice questionable. 100,101<br />
However, the neonate is not yet mentally capable of psychologic -